Pre-transplant and post-transplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejection

International Urology and Nephrology

Volumn 41, Issue 3, 2009, Pages 687-693

  Nafar, Mohsen ^a   Farrokhi, Farhat ^a   Vaezi, Mohammad ^b   Entezari, Amir Ebrahim ^a   Pour Reza Gholi, Fatemeh ^a   Firoozan, Ahmad ^a   Eniollahi, Behzad ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute rejection; Diagnosis; Graft survival; Kidney transplantation; Soluble CD30

Indexed keywords

CD30 ANTIGEN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; RENAL GRAFT DYSFUNCTION; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ADULT; ANTIGENS, CD30; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 67649946588     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9505-x     Document Type: Article

References (15)

1. Pelzl S, Opelz G, Wiesel M, Schnulle P, Schonemann C, Dohler B, Susal C (2002) Soluble CD30 as a predictor of kidney graft outcome. Transplantation 73:3-6. doi: 10.1097/00007890-200201150-00002
2. Weimer R, Zipperle S, Daniel V, Carl S, Staehler G, Opelz G (1996) Pretransplant CD4 helper function and interleukin 10 response predict risk of acute kidney graft rejection. Transplantation 62:1606-1614. doi: 10.1097/00007890-199612150-00014
3. Qian S, Li W, Li Y, Fu F, Lu L, Fung JJ, Thomson AW (1996) Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation 62:1709-1714. doi: 10.1097/ 00007890-199612270-00002
4. Susal C, Pelzl S, Dohler B, Opelz G (2002) Identification of highly responsive kidney transplant recipients using pre-transplant soluble CD30. J Am Soc Nephrol 13:1650-1656. doi: 10.1097/ 01.ASN.0000014256.75920.5B
5. Cinti P, Pretagostini R, Arpino A, Tamburro ML, Mengasini S, Lattanzi R, De Simone P, Berloco P, Molajoni ER (2005) Evaluation of pre-transplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations. Transplantation 79:1154-1156. doi: 10.1097/01.TP.0000152660.56055.53
6. Pelzl S, Opelz G, Daniel V, Wiesel M, Susal C (2003) Evaluation of post-transplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 75:421-423. doi: 10.1097/ 01.TP.0000044702.18327.66
7. Dong W, Shunliang Y, Weizhen W, Qinghua W, Zhangxin Z, Jianming T, He W (2006) Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30. Transpl Immunol 16:41-45. doi: 10.1016/j.trim.2006.02.005
8. Matinlauri IH, Kyllonen LE, Salmela KT, Helin H, Pelzl S, Susal C (2005) Serum sCD30 in monitoring of alloresponse in well HLA-matched cadaveric kidney transplantations. Transplantation 80:1809-1812. doi: 10.1097/ 01.tp.0000188175.66835.c6
9. Sengul S, Keven K, Gormez U, Kutlay S, Erturk S, Erbay B (2006) Identification of patients at risk of acute rejection by pre-transplantation and post-transplantation monitoring of soluble CD30 levels in kidney transplantation. Transplantation 81:1216-1219. doi: 10.1097/01.tp.0000203324.49969.30
10. Barbano G, Cappa F, Prigione I, Pistoia V, Cohen A, Chiesa S, Gusmano R, Perfumo F (2001) Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone. Nephrol Dial Transplant 16:1807-1813. doi: 10.1093/ndt/16.9.1807
11. Beaurain G, Naret C, Marcon L, Grateau G, Drueke T, Urena P, Nelson DL, Bach JF, Chatenoud L (1989) In vivo T cell pre-activation in chronic uremic hemodialyzed and non-hemodialyzed patients. Kidney Int 36:636-644. doi: 10.1038/ki.1989.240
12. Nakao K, Nagake Y, Okamoto A, Ichikawa H, Yamamura M, Makino H (2002) Serum levels of soluble CD26 and CD30 in patients on hemodialysis. Nephron 91:215-221. doi: 10.1159/000058395
13. Rajakariar R, Jivanji N, Varagunam M, Rafiq M, Gupta A, Sheaff M, Sinnott P, Yaqoob MM (2005) High pre-transplant soluble CD30 levels are predictive of the grade of rejection. Am J Transplant 5:1922-1925. doi: 10.1111/j.1600-6143.2005.00966.x
14. Altermann W, Schlaf G, Rothhoff A, Seliger B (2007) High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection? Nephrol Dial Transplant 22:2795-2799. doi: 10.1093/ndt/gfm397
15. Kovac J, Arnol M, Vidan-Jeras B, Bren AF, Kandus A (2008) Does pre-transplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation? Transplant Proc 40:1357-1361. doi: 10.1016/j.transproceed.2008.03.092